Literature DB >> 3874965

Regulatory functions of T- and accessory-cells for hepatitis B surface antigen induced specific antibody production and proliferation of human peripheral blood lymphocytes, in vitro.

U Hellström, S Sylvan, P Lundbergh.   

Abstract

In vitro assays for lymphocyte proliferation and production of specific antibodies to hepatitis B surface antigen (HBsAg) are described. Peripheral B-cells from healthy donors with acquired immunity after infection with hepatitis B virus (HBV) were activated by purified HBsAg at low concentrations (approximately 2.5 ng/ml), into plasma cell differentiation and maturation to specific immunoglobulin (anti-HBs) secretion. This process was dependent upon and strictly regulated by T-cells and anti-HBs secretion of IgG class was registered at T/B ratios less than or equal to 4.0. Higher T/B ratios provoked secretion of large amounts of total IgM but no specific antibodies. Maximal DNA-synthesis was induced in purified T-cells or the total peripheral blood lymphocyte population from HBV-immune donors at higher concentrations of HBsAg (7-15 ng/ml and 60-125 ng/ml respectively). Proliferation was dependent upon and regulated by monocytic cells. Ten percent of autologous monocytic cells within the cell cultures was optimal, while excessive amounts effectively suppressed the proliferative response. DNA-synthesis was low and extremely shortlived and the induction phase to maximal proliferation for different HBV immune donors varied between 5-8 days in culture.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874965

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  8 in total

1.  The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen.

Authors:  P J Wismans; J van Hattum; G C De Gast; H J Endeman; J Poel; B Stolk; T Maikoe; G C Mudde
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

2.  Characterization of hepatitis B surface antigen (HBsAg) induced interleukin-2 secretion in chronic asymptomatic carriers of HBsAg.

Authors:  S P Sylvan; U B Hekkström
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  HBsAg-induced antigen-specific T and B lymphocyte responses in chronic hepatitis B virus carriers and immune individuals.

Authors:  A Fernan; C J Cayzer; W G Cooksley
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

4.  HBsAg-induced interferon-gamma secretion in T cells from asymptomatic HBsAg carriers and HB-immune donors in vitro.

Authors:  S P Sylvan; U B Hellström
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

5.  Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers.

Authors:  S P Sylvan; U B Hellström; P R Lundbergh
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

6.  Characterization of cell mediated immune responses to the hepatitis B core protein in man.

Authors:  S P Sylvan; U B Hellström; B Flehmig
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

7.  Regulation of the immune response in Plasmodium falciparum malaria: IV. T cell dependent production of immunoglobulin and anti-P. falciparum antibodies in vitro.

Authors:  L Kabilan; M Troye-Blomberg; M E Patarroyo; A Björkman; P Perlmann
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

8.  In vitro immune responses to hepatitis B surface antigen (Pre-S2 and S) following remote infection by hepatitis B virus in humans.

Authors:  T R Cupps; J H Hoofnagle; R W Ellis; W J Miller; L Seeff; A Guerrera; J L Gerin; S A Haas-Smith
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.